BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8675213)

  • 1. Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.
    Boshell M; McLeod J; Walker L; Hall N; Patel Y; Sansom D
    Immunology; 1996 Apr; 87(4):586-92. PubMed ID: 8675213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
    D'Orazio JA; Stein-Streilein J
    Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An MHC class II-expressing T cell clone presenting conventional antigen lacks the ability to present bacterial superantigen.
    Sun D; Woodland DL; Coleclough C; Wendling U; Reske K
    Int Immunol; 1995 Jul; 7(7):1079-85. PubMed ID: 8527405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling.
    Hargreaves RG; Borthwick NJ; Gilardini Montani MS; Piccolella E; Carmichael P; Lechler RI; Akbar AN; Lombardi G
    J Immunol; 1997 Apr; 158(7):3099-107. PubMed ID: 9120262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.
    Perabo FG; Willert PL; Wirger A; Schmidt DH; Von Ruecker A; Mueller SC
    Anticancer Res; 2005; 25(5):3565-73. PubMed ID: 16101181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens.
    Muraille EM; De Becker G; Bakkus M; Thielemans K; Urbain J; Moser M; Leo O
    Int Immunol; 1995 Feb; 7(2):295-304. PubMed ID: 7734424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
    Soares LR; Rivas A; Ruegg C; Engleman EG
    Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
    Brogan PA; Shah V; Klein N; Dillon MJ
    Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationship between MHC class II-superantigen complexes and the balance of T cell activation versus death.
    Lavoie PM; McGrath H; Shoukry NH; Cazenave PA; Sékaly RP; Thibodeau J
    J Immunol; 2001 Jun; 166(12):7229-37. PubMed ID: 11390471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I molecule serves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells.
    Häffner AC; Zepter K; Elmets CA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3037-42. PubMed ID: 8610164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand.
    Renno T; Hahne M; Tschopp J; MacDonald HR
    J Exp Med; 1996 Feb; 183(2):431-7. PubMed ID: 8627156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
    Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
    J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired responses of peripheral blood mononuclear cells to staphylococcal superantigen in patients with severe atopic dermatitis: a role of T cell apoptosis.
    Yoshino T; Asada H; Sano S; Nakamura T; Itami S; Tamura M; Yoshikawa K
    J Invest Dermatol; 2000 Feb; 114(2):281-8. PubMed ID: 10651987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
    LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
    J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation.
    Nisini R; Fattorossi A; Ferlini C; D'Amelio R
    Eur J Immunol; 1996 Apr; 26(4):797-803. PubMed ID: 8625970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.